Muscle Wasting in the Hospitalised COPD Patients—How Can it Be Prevented and Treated?
- 30 Downloads
Purpose of Review
COPD exacerbations are widely recognised as a significant cause of mortality and morbidity through their impact on respiratory function but their effect on skeletal muscle function and mass receives less attention. In this article, we review the association of this entity with COPD, the potential contributing factors, and the evidence behind the interventions available to manage this condition with a focus on the elderly population.
In patients with COPD, there has been a paradigm shift from the focus on body weight and mass index to a more detailed assessment of the loss of muscle mass and function defined as sarcopaenia. Factors that can potentially lead to sarcopaenia has been the subject of multiple basic science and translational research studies. Interventions that have been proven to be associated with clinically significant outcomes in COPD patients include early mobilisation, inpatient exercise programmes, early pulmonary rehabilitation, and nutritional interventions. Prolonged courses of steroids following an acute exacerbation are non-beneficial and can lead to loss of muscle function.
Multiple factors can potentially contribute to sarcopaenia among patients admitted with COPD exacerbations and should be identified early and treated in a multidisciplinary setting. Nutritional interventions, early mobilisation, and limitation of systemic steroid prescribing are simple and effective interventions that should be utilised.
KeywordsSarcopaenia Chronic obstructive pulmonary disease Exacerbation
Compliance with Ethical Standards
Conflict of Interest
Tara Cahill and Mohammed Ahmed declare no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 1.• Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr Edinb Scotl. 2014;33(5):737–48. Provides a very detailed yet succinct description of sarcopaenia and its causative factors. CrossRefGoogle Scholar
- 3.Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998–2009. NCHS Data Brief. 2011;63:1–8.Google Scholar
- 7.World Health Organization. Chronic Obstructive Pulmonary Disease (COPD). 2018. Available from: http://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
- 8.Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H, Murio C, Ros F, Vidal R, IMPAC Study Group. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004;59(5):387–395.Google Scholar
- 9.Donaldson GC, Wedzicha JA. COPD exacerbations .1: epidemiology. Thorax 2006;61(2):164–168.Google Scholar
- 17.Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, Antó JM, Estudi del Factors de Risc d’Agudització de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003;58(2):100–105.Google Scholar
- 19.• da Rocha Lemos Costa TM, Costa FM, Moreira CA, Rabelo LM, Boguszewski CL, Borba VZC. Sarcopenia in COPD: relationship with COPD severity and prognosis. J Bras Pneumol Publicacao Of Soc Bras Pneumol E Tisilogia. 2015;41(5):415–21. This paper evaluates the prevalence of sarcopaenia in COPD patients and also confirms that sarcopaenia correlates with a worse prognosis in COPD. Google Scholar
- 20.de Morton NA, Keating JL, Jeffs K. Exercise for acutely hospitalised older medical patients. Cochrane Database Syst Rev. 2007;1:CD005955.Google Scholar
- 21.Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. In: The Cochrane Library [Internet]. John Wiley & Sons, Ltd; 2016 [cited 2018 May 12]. Available from: https://doi.org/10.1002/14651858.CD005305.pub4/full
- 22.Rodriguez DA, Rodo-Pin A, Guerrero M, Coll R, Huerta A, Soler N, et al. Impact of step exercises as an early intervention during COPD exacerbation. Eur Respir J. 2016;48(suppl 60):PA2061.Google Scholar
- 35.Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr Edinb Scotl. 2010;29(2):154–9.CrossRefGoogle Scholar
- 36.Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39(4):412–423.Google Scholar
- 40.Joseph A-M, Adhihetty PJ, Buford TW, Wohlgemuth SE, Lees HA, Nguyen LM-D, et al. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals. Aging Cell. 2012;11(5):801–9.CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Bua EA, McKiernan SH, Wanagat J, McKenzie D, Aiken JM. Mitochondrial abnormalities are more frequent in muscles undergoing sarcopenia. J Appl Physiol Bethesda Md 1985. 2002;92(6):2617–24.Google Scholar